Associate professor of medicine and neurology, and director, Duke ALS Clinic, Duke Health; and chief, Department of Neurology, Durham Veterans Affairs Medical Center.
Ways to Optimize Trials for ALS Drug Development: Richard Bedlack, MD, PhD, MS
The director of the Duke ALS Clinic at Duke Health discussed the advances in drug development for ALS and ways to evolve future trials to get optimal therapeutic benefit. [WATCH TIME: 3 minutes]
Challenges With Access, Delivery of New ALS Therapeutics: Richard Bedlack, MD, PhD, MS
The director of the Duke ALS Clinic at Duke Health provided perspective on the issues with getting newly approved ALS therapies to patients who need them the most. [WATCH TIME: 4 minutes]
Ongoing Clinical Trials and the Future of ALS
Key opinion leaders review the study design and mechanisms of action for drugs in ongoing clinical trials and consider the future of amyotrophic lateral sclerosis (ALS).
Advancements in Clinical Trial Design in ALS
A panel of experts provides insights into recent improvements in clinical trial design in amyotrophic lateral sclerosis (ALS) and discusses implications of recent clinical trial results.
Approaches to Pharmacologic Management of ALS
Expert neurologists discuss clinical trial design and FDA approvals for current approaches to pharmacologic management of amyotrophic lateral sclerosis (ALS) and share personal experiences.
Challenges of Respiratory Care in Patients with ALS
Key opinion leaders consider the importance of respiratory care in ALS by discussing immunization against respiratory illness as well as the use of non-invasive ventilation.
Building a Dialogue on Life Sustaining Care in ALS
Panelists share approaches for building a dialogue on life sustaining care such as invasive ventilation and discuss the importance of social and cultural factors for patients and families.
Multidisciplinary Approach to Palliative Care in ALS
Expert neurologists discuss the importance of a multidisciplinary approach to the management of symptoms for palliative care in amyotrophic lateral sclerosis (ALS).
Diagnosis and Management of ALS During COVID-19
A panel of key opinion leaders provides insight into how COVID-19 has continued to impact the diagnosis and management of patients with amyotrophic lateral sclerosis (ALS).
Genetic Testing for Patients with ALS
Experts in neurology give insight into recent advancements in genetic testing for amyotrophic lateral sclerosis (ALS) and discuss what factors to consider when offering it to patients.
Diagnostic Criteria and Staging Systems in ALS
A panel of experts considers the usefulness of diagnostic criteria and disease staging systems for patients with amyotrophic lateral sclerosis (ALS) as entry criteria for clinical trials.
Counseling Patients on ALS Progression and Prognosis
Key opinion leaders ALS care comment on best practices when communicating with patients about the unpredictability of disease progression and prognosis.
Diagnosing ALS: Common Mimics
Panelists provide insight into what primary care physicians should consider when differentiating amyotrophic lateral sclerosis (ALS) from conditions with similar presentations.
Diagnosing ALS: Signs and Symptoms
Expert neurologists discuss the variability of signs and symptoms as well as other factors to consider when diagnosing patients with amyotrophic lateral sclerosis (ALS).
An Overview of Causes and Risk Factors for ALS
A panel of key opinion leaders in neurology provides an overview of the prevalence of amyotrophic lateral sclerosis (ALS) and discusses potential causes and risk factors.
2 Clarke Drive Cranbury, NJ 08512